4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001209191-15-038916
$TVRDCIK 0001346830operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:49 PM ET
Size
4.8 KB
Accession
0001209191-15-038916
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2015-05-01$10.64/sh−7,262$77,268→ 336,774 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:49 PM ET
- Size
- 4.8 KB